• Chemistry at Vertex Pharmaceuticals

Eric Cheng, MD, MBA

  • 14+ years of experience in biomedical research and drug development

  • PhD in Biochemistry

  • Instructor at Harvard Medical School

Jin (Jim) Wang

CO-FOUNDER, CBO (PART-TIME)

Team

  • Managing Director at Danforth Advisors with deep financial expertise

CFO (PART-TIME)
  • Investment Director at Jianxin Capital

FOUNDER, CSO
  • 20+ years of experience in founding, investing, and managing innovative therapeutic R&D companies

John Tagliamonte, MBA

  • 14+ years of translational research experience in oncology

EXECUTIVE CHAIRMAN

Daniel Geffken, MBA

CORPORATE DEVELOPMENT, COO

Paul D. Rennert, PhD

Advisors

Tim Feng, PhD

  • 20+ years of experience in business development

  • ​Formerly at Johnson and Johnson, ImmunoGen, Anchor, and Oxyrane

Yeung Heung Yeung, PhD

Simon Fricker, PhD

WntRx's team is comprised of world-leading cancer researchers and biotech industry innovators whose work lies at the forefront of cancer therapeutics development. Management is guided by distinguished advisors, including industry leaders and highly experienced investors and entrepreneurs.

  • Immuno-oncology at Aleta, Biogen, and X-Rx


  • President of Venture Leader Group

  • Former President of TEEC Angel Fund 

  • Executive Vice President of Technology and Research, Microsoft

Robert Perni, PhD

CANCER BIOLOGY AND ONCOLOGY, DIRECTOR
  • Cancer biology at AnorMed and Genzyme

Andrew X. Zhu, MD, PhD

  • Director of Liver Cancer Research at the Massachusetts General Hospital

  • Professor of Medicine, Harvard Medical School

Management

David Zhu, PhD